Accuracy of pharmacy and coded‐diagnosis information in identifying tuberculosis in patients with rheumatoid arthritis

Previous studies suggest that disease‐modifying anti‐rheumatic drugs (DMARDs) increase tuberculosis (TB) risk. The accuracy of pharmacy and coded‐diagnosis information to identify persons with TB is unclear.

[1]  Roger Baxter,et al.  The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti‐tumor necrosis factor therapy , 2011, Pharmacoepidemiology and drug safety.

[2]  S. Suissa,et al.  Antirheumatic drugs and the risk of tuberculosis. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  A. Gibofsky.  American College of Rheumatology. , 2002, Journal of the Medical Association of Georgia.

[4]  J. Keane,et al.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. , 2001, The New England journal of medicine.

[5]  Vital Hepatitis Std Aids,et al.  Reported tuberculosis in the United States 2013 , 2014 .

[6]  Jeffrey N Katz,et al.  Validation of rheumatoid arthritis diagnoses in health care utilization data , 2011, Arthritis research & therapy.

[7]  S. Suissa,et al.  Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada. , 2009, Arthritis and rheumatism.

[8]  J. Gómez-Reino,et al.  Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. , 2003, Arthritis and rheumatism.

[9]  M. Hudson,et al.  Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis. , 2007, Rheumatology.

[10]  Jeffrey R Curtis,et al.  American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. , 2008, Arthritis and rheumatism.

[11]  Richard Platt,et al.  Pharmacy Data for Tuberculosis Surveillance and Assessment of Patient Management , 2004, Emerging infectious diseases.